118.90000 USD
0.8
0.67%
Last update Dec 17, 4:29 PM GMT
Main market
Day range
118
120.14000
Previous close
119.70000
Open
118.35000
Access this stock data via API
Subscribe
Gilead Sciences Inc.
118.90
0.80
0.67%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 28.8B 27.1B 27.3B 27.3B
Cost of revenue 6.3B 6.5B 5.7B 6.6B
Gross profit 22.5B 20.6B 21.6B 20.7B
Operating expense
Research & development 5.9B 5.7B 5.0B 4.6B
Selling general and admin 6.1B 6.1B 5.7B 5.2B
Other operating expenses
Operating income 10.5B 8.8B 11.0B 10.9B
Non operating interest income
Income 281M
Expense 977M 944M 935M 1.0B
Other income expense -9.1B -1.0B -4.2B -1.6B
Pretax income 690M 6.9B 5.8B 8.3B
Tax provision 211M 1.2B 1.2B 2.1B
Net income 480M 5.6B 4.6B 6.2B
Basic EPS 0.4 4.5 3.7 5.0
Diluted EPS 0.4 4.5 3.6 4.9
Basic average shares 1.2B 1.2B 1.3B 1.3B
Diluted average shares 1.2B 1.2B 1.3B 1.3B
EBITDA 13.6B 11.7B 12.5B 12.3B
Net income from continuing op. 480M 5.6B 4.6B 6.2B
Minority interests 0 52M 26M 24M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 32 minutes

13:57
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).